Product Information

DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.5625 per EA under NDC 00115149001. Its NADAC has been published 537 times since Aug 3, 2016.

FDA first approved this application on Feb 16, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1

NDC

00115149001

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076852

FDA Approved

2/16/2016

TE Code

AB1

On Market Since

2/16/2016

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 537 times since Aug 3, 2016, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5625 per EA
All-time high$3.3103 (Sep 14, 2016)
All-time low$0.4173 (May 22, 2024)
52-week high$0.5625
52-week low$0.4895
Median price$0.6948
Average price$1.1648
Largest weekly change-47.3% (Apr 22, 2020)
Weeks tracked537
Tracking sinceAug 3, 2016

Price History

1W

0.0%

1M

+14.9%

3M

+9.5%

6M

+2.1%

1Y

+2.8%

3Y

-1.0%

5Y

-3.8%

All

-82.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.5625 per EA (NDC 00115149001), effective Nov 11, 2026.

How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 82.9%. It has been tracked across 537 weekly CMS publications since Aug 3, 2016.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?

Since Aug 3, 2016, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $3.3103 (Sep 14, 2016), with a median of $0.6948 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 25 MG CAP, is $0.5122 per EA — about 9% below DEXTROAMP-AMPHET ER 25 MG CAP.

Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?

DEXTROAMP-AMPHET ER 25 MG CAP (NDC 00115149001) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.